Top message

I am honored to have assumed the role of president of Riken Vitamin.

Riken Vitamin has set its medium- to long-term vision toward fiscal year 2034:
“To become a company that supports a sustainable society through specialty products and services while achieving continuous growth.”

In May 2025, we announced our Medium-Term Management Plan 2027. This plan represents a key setp toward our 2034 goal of becoming a global specialty company that contributes to food and health worldwide, with a target of increasing our overseas sales ratio to 35%.

Under the previous plan, we worked to achieve our performance targets and improve capital efficiency. However, we recognize that there is still room to enhance our corporate valuation. Going forward, we will more clearly communicate our growth potential and earning power, while deepening engagement with capital markets.

Our three core businesses—Food, Improving Agents, and Healthcare—do not operate in isolation. Rather, they work in close collaboration to create value-added products and services. We believe this integrated approach is the foundation of our sustainable competitive advantage.

In response to structural changes such as a maturing domestic market and a growing global population, we are positioning overseas markets as key growth drivers. To capture long-term growth opportunities for our specialty products, we are actively investing in facilities in facilities and strengthening our global operations.

In Japan, we are nurturing market-creating products in the BtoC area, while also responding to demand for convenience and health-consciousness in the BtoB area. At the same time, we are enhancing our ability to propose solutions to social issues such as food loss and waste, thereby building sustainable competitive strength.

We are also focused on strengthening our human capital by fostering a workplace where diverse talent can thrive autonomously and contribute to the Company’s growth.

In terms of capital policy, we have raised our target dividend payout ratio from 30% to 40%, and will also make flexible use of share buybacks to enhance shareholder returns.

We sincerely appreciate the continued support and trust of our shareholders and investors.